Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 1
2016 1
2017 1
2020 1
2021 3
2022 7
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh TD, Spigelman M, Moore DAJ, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL Study Collaborators. Nyang'wa BT, et al. N Engl J Med. 2022 Dec 22;387(25):2331-2343. doi: 10.1056/NEJMoa2117166. N Engl J Med. 2022. PMID: 36546625 Clinical Trial.
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Patil SB, Tamirat M, Khazhidinov K, Ardizzoni E, Atger M, Austin A, Baudin E, Bekhit M, Bektasov S, Berikova E, Bonnet M, Caboclo R, Chaudhry M, Chavan V, Cloez S, Coit J, Coutisson S, Dakenova Z, De Jong BC, Delifer C, Demaisons S, Do JM, Dos Santos Tozzi D, Ducher V, Ferlazzo G, Gouillou M, Khan U, Kunda M, Lachenal N, LaHood AN, Lecca L, Mazmanian M, McIlleron H, Moreau M, Moschioni M, Nahid P, Osso E, Oyewusi L, Panda S, Pâquet A, Thuong Huu P, Pichon L, Rich ML, Rupasinghe P, Salahuddin N, Sanchez Garavito E, Seung KJ, Velásquez GE, Vallet M, Varaine F, Yuya-Septoh FJ, Mitnick CD, Guglielmetti L. Patil SB, et al. Among authors: rupasinghe p. Trials. 2023 Nov 30;24(1):773. doi: 10.1186/s13063-023-07701-6. Trials. 2023. PMID: 38037119 Free PMC article.
Balancing access to BPaLM regimens and risk of resistance.
Van Rie A, Walker T, de Jong B, Rupasinghe P, Rivière E, Dartois V, Sonnenkalb L, Machado D, Gagneux S, Supply P, Dreyer V, Niemann S, Goig G, Meehan C, Tagliani E, Cirillo DM. Van Rie A, et al. Among authors: rupasinghe p. Lancet Infect Dis. 2022 Oct;22(10):1411-1412. doi: 10.1016/S1473-3099(22)00543-6. Epub 2022 Aug 22. Lancet Infect Dis. 2022. PMID: 36007529 No abstract available.
Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin.
Rupasinghe P, Ashraf A, Barreda N, Parveen S, Zubair M, Calderon R, Asif S, Hirani N, Chingisova L, Bulane A, Hang PT, Ha DT, Ardizzoni E, Kursheed N, De Rijk WB, Rigouts L, Guglielmetti L, Mitnick C, de Jong BC. Rupasinghe P, et al. Antimicrob Agents Chemother. 2024 Mar 27:e0170123. doi: 10.1128/aac.01701-23. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 38534101 No abstract available.
An analytical cross-sectional study to describe the mental health status of doctors in three selected tertiary care hospitals and medical undergraduates, Colombo, Sri Lanka during the first wave of COVID-19 pandemic.
Galhenage J, Perera I, Rupasinghe P, De Silva AP, Suraweera C. Galhenage J, et al. Among authors: rupasinghe p. Asian J Psychiatr. 2022 Jan;67:102945. doi: 10.1016/j.ajp.2021.102945. Epub 2021 Nov 26. Asian J Psychiatr. 2022. PMID: 34879322 Free PMC article. No abstract available.
17 results